The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook
Joint Authors
Rose, William Nicholas
Miller, Vandana
Jennings, Stephen R.
Wigdahl, Brian
Krebs, Fred C.
Source
Journal of Immunology Research
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-14, 14 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-05-25
Country of Publication
Egypt
No. of Pages
14
Main Subjects
Abstract EN
Dendritic cells (DC) are key phagocytic cells that play crucial roles in both the innate and adaptive immune responses against the human immunodeficiency virus type 1 (HIV-1).
By processing and presenting pathogen-derived antigens, dendritic cells initiate a directed response against infected cells.
They activate the adaptive immune system upon recognition of pathogen-associated molecular patterns (PAMPs) on infected cells.
During the course of HIV-1 infection, a successful adaptive (cytotoxic CD8+ T-cell) response is necessary for preventing the progression and spread of infection in a variety of cells.
Dendritic cells have thus been recognized as a valuable tool in the development of immunotherapeutic approaches and vaccines effective against HIV-1.
The advancements in dendritic cell vaccines in cancers have paved the way for applications of this form of immunotherapy to HIV-1 infection.
Clinical trials with patients infected with HIV-1 who are well-suppressed by antiretroviral therapy (ART) were recently performed to assess the efficacy of DC vaccines, with the goal of mounting an HIV-1 antigen-specific T-cell response, ideally to clear infection and eliminate the need for long-term ART.
This review summarizes and compares methods and efficacies of a number of DC vaccine trials utilizing autologous dendritic cells loaded with HIV-1 antigens.
The potential for advancement and novel strategies of improving efficacy of this type of immunotherapy is also discussed.
American Psychological Association (APA)
Rose, William Nicholas& Miller, Vandana& Jennings, Stephen R.& Wigdahl, Brian& Krebs, Fred C.. 2020. The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook. Journal of Immunology Research،Vol. 2020, no. 2020, pp.1-14.
https://search.emarefa.net/detail/BIM-1187693
Modern Language Association (MLA)
Rose, William Nicholas…[et al.]. The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook. Journal of Immunology Research No. 2020 (2020), pp.1-14.
https://search.emarefa.net/detail/BIM-1187693
American Medical Association (AMA)
Rose, William Nicholas& Miller, Vandana& Jennings, Stephen R.& Wigdahl, Brian& Krebs, Fred C.. The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook. Journal of Immunology Research. 2020. Vol. 2020, no. 2020, pp.1-14.
https://search.emarefa.net/detail/BIM-1187693
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1187693